Figure 2.
Effects of Ca-EDTA, aztreonam and ceftazidime/avibactam and their combination in vitro
(A) biofilm biovolume and (B) biofilm cell viability (%) of carbapenemase-producing K. pneumoniae clinical isolates (n = 29) at different time intervals. All experiments in a–b was performed as three biologically independent experiments, and the mean ± s.d. is shown. p values were determined using an unpaired, two-tailed Student’s t test.
